
Sarepta Therapeutics the leader in precision genetic medicine for rare diseases
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of…












